SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view

Giuseppe Zampino, F. Spada, S. Pellicori, G. Zampino, L. Funicelli, L. Gervaso, A. Laffi, M. Rubino, R. Garcia-Carbonero, N. Fazio

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

Abstract

Primary neuroendocrine tumors of the thymus are extremely rare. In patients with advanced disease, tumor growth control, and sometimes also syndrome control are the main goals of systemic therapy. Unfortunately, no standard therapies are available in clinical practice; therefore, clinical studies are strongly recommended. Axitinib (AXI) is a tyrosine kinase inhibitor, currently under investigation in an international phase II/III trial including thymic neuroendocrine tumors. Over the past 5 months, the entire world has been facing a devastating medical emergency brought about by a pandemic due to a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China, in late 2019. Since then, health professionals have been expending all their efforts on trying to provide the best available treatments for patients involved. Patients with cancer, especially those with thoracic involvement, are at higher risk of coronavirus disease 19 (COVID-19) and its complications because of their immunosuppressive status caused by the cancer and the anticancer therapies. As it remains unclear how to optimally manage such patients, we wished to report our experience with a patient with a metastatic neuroendocrine tumor of the thymus infected with SARS-CoV-2 in the hope that it may provide some insights and reflections on the management of cancer patients during this challenging time in our history.
Lingua originaleEnglish
pagine (da-a)6-10
Numero di pagine5
RivistaENDOCRINE
Volume70
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • Aged
  • Axitinib
  • Azithromycin
  • Betacoronavirus
  • COVID-19
  • Carcinoid Tumor
  • Comorbidity
  • Coronavirus Infections
  • Humans
  • Hydroxychloroquine
  • Italy
  • Male
  • NET
  • Neuroendocrine Tumors
  • Neuroendocrine tumors
  • Pandemics
  • Pneumonia, Viral
  • Protein-Tyrosine Kinases
  • Randomized Controlled Trials as Topic
  • SARS-CoV-2
  • Thymus
  • Thymus Neoplasms
  • Tomography, X-Ray Computed
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view'. Insieme formano una fingerprint unica.

Cita questo